Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides fromCampylobacter jejuni

This publication has 21 references indexed in Scilit:

• Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.
  Proceedings of the National Academy of Sciences, 1995
• Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants.
  Proceedings of the National Academy of Sciences, 1994
• Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.
  Journal of Clinical Oncology, 1994
• Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma
  Vaccine, 1994
• Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides
  European Journal of Biochemistry, 1993
• Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants
  Immunobiology, 1993
• Ganglioside expression on human malignant melanoma assessed by quantitative immune thin‐layer chromatography
  International Journal of Cancer, 1993
• Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse
  Cancer Immunology, Immunotherapy, 1989
• Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.
  Proceedings of the National Academy of Sciences, 1987
• [20] Electrophoretic separation of lipopolysaccharide monomers differing in polysaccharide length
  Published by Elsevier ,1987